SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTC Markets: MNTR) announced the launch of its $125 Million Direct Cancer Equity Funding Program. “Our shareholders have told us they want their purchase of Mentor stock to fund the development of leading-edge cancer solutions,” reports CEO, Chester Billingsley. “Trading cancer shares can be profitable, but socially responsible investing is best served by injecting funds directly.” Mentor’s Direct Cancer Equity Funding Program was created to translate an investor share purchase into cash funding for cancer breakthroughs.
